Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines

(2019) Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines. Journal of Research in Pharmacy Practice. 228-+. ISSN 2319-9644

[img]
Preview
Text
10864.pdf

Download (855kB) | Preview

Official URL: WOS:000506389200010

Abstract

Cutaneous leishmaniasis is caused by a flagellated parasite and transmitted through a bite by bloodsucking sand-flies.[1] Cutaneous leishmaniasis is characterized by ulcerative skin lesions. This is an endemic disease in the Middle East, especially Iran, Afghanistan, Pakistan, Bangladesh, Indian, and Nepal.[2] Since the 1940s, pentavalent antimony compounds have been considered as the first line of treatment for all forms of leishmaniasis. Meglumine antimoniate and sodium stibogluconate are the well-known pentavalent antimony agents.[3] Glucantime (Sanofi Aventis, France) is a brand product of meglumine antimoniate, which is supplied in 5 mL colorless ampules with concentration 300 mg/mL. Every five ampules are packed in a box, and there are not any visible particles in Glucantime ampules

Item Type: Article
Keywords: Pharmacology & Pharmacy
Subjects: QV Pharmacology > QV 701-835 Pharmacy and Pharmaceutics
Divisions: Faculty of Medicine > Departments of Clinical Sciences > Department of Skin
Faculty of Pharmacy and Pharmaceutical Sciences > Student Research Committee
Skin Diseases and Leishmaniasis Research Center
Page Range: 228-+
Journal or Publication Title: Journal of Research in Pharmacy Practice
Journal Index: ISI
Volume: 8
Number: 4
Identification Number: https://doi.org/10.4103/jrpp.JRPP₁₉₈₄
ISSN: 2319-9644
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/10864

Actions (login required)

View Item View Item